Hutrope 100 IU - Hubio Pharm

The evolution of HGH therapy took a critical turn in 1985, when cadaver-derived hormone was banned due to contamination concerns. That same year, somatrem became the first recombinant HGH, developed by Genentech using DNA technology. Though its amino acid sequence differed slightly from the body’s natural version, it proved the feasibility of synthetic production. Not long after, somatropin was released, offering a hormone identical to what the body produces. Since then, somatropin has become the primary form of HGH used in endocrinology and performance medicine.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Hutrope 100 IU by Hubio Pharm, consult with your doctor or healthcare professional.